ABT has good news synchronously with price action dip LONG
ABT on the one-hour chart is in a sideways diverging channel with Bollinger Bands overlaid
and now compressing. In Europe, the new implantable cardiac monitor has tentative approval
producing a growth narrative. Relative volumes and volatility have decreased heading into the
pivot. ABT is in what is projected to be one of the hottest sectors this year. It pays dividends
consistently. I am taking a long trade here. Targets are $120 and $130. A predictive algo
validates the idea in its forecast
Medtechstocks
OCGN pumps on dismissal of investor lawsuit LONGOCGN has been a great swing trade after buying bad news. The good news has replaced the
bad. Earnings are in three days. Price well below ATH. November earnings were a beat
meaning this risky Med Tech penny stock had a lower cash burn than projected. Now
legal costs will disappear. Going long with a decent position expecting a better earnings.
In law, the Latin phrase res ipsa loquitur is sometimes used. Here it aptly applies to
Ocugen.